For research use only.
Verified Samples |
Verified Samples in IHC: Human colorectal cancer, Human prostate cancer |
Dilution | IHC 1:50-1:100 |
Clonality | Polyclonal |
Immunogen | Synthetic peptide of human GANAB |
Abbre | GANAB |
Synonyms | Alpha glucosidase II alpha subunit, Alpha-glucosidase 2, G2AN, GANAB, Glu II, GluII, Glucosidase II alpha, Glucosidase II subunit alpha, Glucosidase alpha neutral AB, KIAA0088, Neutral alpha glucosidase AB, Neutral alpha glucosidase AB precursor, Neutral alpha- |
Swissprot | |
Cellular Localization | Endoplasmic reticulum. Golgi apparatus. Melanosome. Identified by mass spectrometry in melanosome fractions from stage I to stage IV. |
Concentration | 0.72 mg/mL |
Buffer | PBS with 0.05% NaN3 and 40% Glycerol,pH7.4 |
Purification Method | Antigen affinity purification |
Research Areas | Cancer, Metabolism, Signal Transduction |
Conjugation | Unconjugated |
Storage | Store at -20°C Valid for 12 months. Avoid freeze / thaw cycles. |
Shipping | The product is shipped with ice pack,upon receipt,store it immediately at the temperature recommended. |
background | Together with the cullin protein ANAPC2, constitutes the catalytic component of the anaphase promoting complex/cyclosome (APC/C), a cell cycle-regulated E3 ubiquitin ligase that controls progression through mitosis and the G1 phase of the cell cycle. The APC/C complex acts by mediating ubiquitination and subsequent degradation of target proteins: it mainly mediates the formation of 'Lys-11'-linked polyubiquitin chains and, to a lower extent, the formation of 'Lys-48'- and 'Lys-63'-linked polyubiquitin chains. May recruit the E2 ubiquitin-conjugating enzymes to the complex. |
Other Clones
{{antibodyDetailsPage.numTotal}} Results
-
{{item.title}}
Citations ({{item.publications_count}}) Manual MSDS
Cat.No.:{{item.cat}}
{{index}} {{goods_show_value}}
Other Formats
{{formatDetailsPage.numTotal}} Results
Unconjugated
-
{{item.title}}
Citations ({{item.publications_count}}) Manual MSDS
Cat.No.:{{item.cat}}
{{index}} {{goods_show_value}}
-
{{item.title}}
IF:{{item.impact}}
Journal:{{item.journal}}
DOI:{{item.doi}}
-
Q{{(FAQpage.currentPage - 1)*pageSize+index+1}}:{{item.name}}
{{item.content}}